Consider the Role of Mounjaro for Type 2 Diabetes

July 2022

You’ll hear buzz about new injectable Mounjaro (tirzepatide)...the first “twincretin” for type 2 diabetes.

Think of Mounjaro as similar to a glucagon-like peptide-1 (GLP-1) agonist...but it’s also a glucose-dependent insulinotropic polypeptide (GIP) agonist. More twincretins are in the works.

GLP-1 and GIP stimulate insulin release, increase satiety, and decrease glucose production.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: MD includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Antidepressants Individualize the Choice of Antidepressant Combos
COVID-19 Help Reduce Barriers to Paxlovid for COVID-19
New Drugs Consider the Role of Mounjaro for Type 2 Diabetes
Dermatitis Answer Questions About Dandruff or Cradle Cap
Liver Disease Guide Management of Nonalcoholic Fatty Liver Disease
Magnesium Answer FAQs About Magnesium Supplements
Biologics Be Familiar With the Laundry List of Uses for Dupixent
Education and Training Be a Standout Preceptor
Supplements Calm the Buzz About Collagen Supplements
Diabetes Consider Subcutaneous Insulin to Manage DKA
Stroke Update Your Intracerebral Hemorrhage Protocols
Psychiatry Explain the Role of SL Dexmedetomidine in Acute Agitation

Consider the Role of Mounjaro for Type 2 Diabetes

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents